CLEVELAND BIOLABS INC 4
4 · CLEVELAND BIOLABS INC · Filed Oct 1, 2014
Insider Transaction Report
Form 4
McGowan Richard
Director
Transactions
- Disposition to Issuer
Series D Warrant
2014-09-29−264,286→ 0 totalExercise: $0.51From: 2009-03-20Exp: 2016-02-13→ Common Stock (264,286 underlying) - Award
Series D Warrant
2014-09-29+264,286→ 264,286 totalExercise: $0.51From: 2009-03-20Exp: 2018-03-30→ Common Stock (264,286 underlying)
Footnotes (1)
- [F1]The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on March 20, 2009 and had an original expiration date of February 13, 2016, which was extended to March 30, 2018 pursuant to the terms of the amendment.